Company intelligence / Profile preview
Axon Neuroscience
Bratislava, Slovakiaaxon-neuroscience.eu ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Axon Neuroscience’s lead asset, AADvac1, is an active immunotherapy targeting pathological tau proteins. In the completed Phase II ADAMANT trial in Alzheimer’s disease, AADvac1 demonstrated a favorable safety profile and robust immune response with statistically significant slowing of neurodegeneration as measured by neurofilament light chain. Clinical benefit was most pronounced in biomarker-defined subgroups. The company has also been selected to participate in a major NIH-funded platform trial for progressive supranuclear palsy starting late 2025.
- Therapeutic areas
- Neurology
- Modalities
- VaccineMonoclonal antibodyImmunotherapy
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
National Institute on Aging / NIH-funded PSP Platform Trial
Beyond the preview
Go deeper on Axon Neuroscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axon Neuroscience.